Skip to content
Home/Companies/Biotech/PerioTrap Pharmaceuticals
PerioTrap Pharmaceuticals

PerioTrap Pharmaceuticals

Biotech·Germany·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns PerioTrap Pharmaceuticals?

PerioTrap Pharmaceuticals is currently owned by bmp Ventures AG through IBG Innovationsfonds (2015 vintage), since 2020.

Hand-verified · updated 2026-07-03

bmp Ventures AG
Investor
bmp Ventures AG
IBG Innovationsfonds · 2015 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive
Websiteperiotrap.com

More from IBG Innovationsfonds

Other portfolio companies in the same fund.

SimFin
Active
FintechGermany· 2022
Wingfield
Wingfield
Active
TMTGermany· 2022
neotiv
neotiv
Active
HealthTechGermany· 2021
Paxly
Paxly
Active
SoftwareGermany· 2021
SOLAR MATERIALS
Solar Materials
Active
EnergyGermany· 2021
AUTOVIO
Autovio
Active
TMTGermany· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track PerioTrap Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on PerioTrap Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue